Significant Ownership of Andrew J. Schwab
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Andrew J. Schwab focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- San Francisco, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
Follow Filing Activity
Follow Andrew J. Schwab with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Andrew J. Schwab
Significant Ownership of Andrew J. Schwab
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SKYE | SKYE BIOSCIENCE, INC. | Common Stock, par value $0.001 | 34% | $15,119,125 | -$203,807 | 11,541,317 | -1.3% | Andrew J. Schwab | 12 Dec 2025 |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | Common Stock | 12% | $8,392,800 | 5,869,091 | Andrew J. Schwab | 09 Sep 2025 | ||
| Rallybio Corp | Common Stock, par value $0.0001 per share | 5.5% | 291,788 | Andrew J. Schwab | 25 Feb 2026 | ||||
| VOR | VOR BIOPHARMA INC. | Common Stock, par value $0.0001 per share | 3.5% | $4,422,863 | 4,422,863 | Andrew J. Schwab | 08 Jul 2025 |
Schedules 13D/G Reported by Andrew J. Schwab:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.